GlassScriptPhysician profile
Franklin L Casey
NPI 1790724748
$1,108.80
in general payments reported to CMS, 2019-2025
32 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.04 · 2020: $53.64 · 2021: $287 · 2022: $129 · 2023: $247 · 2024: $195 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559 · Entertainment: $33.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.06 |
| Entertainment | $33.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $135.75 | 2024 | Venaseal |
| Pfizer INC. | $110.09 | 2020-2025 | |
| Glaxosmithkline, LLC. | $84.28 | 2020-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $73.67 | 2021-2023 | Vraylar |
| Biogen, INC. | $67.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.00 | 2024-2025 | Jascayd |
| Amgen INC. | $47.82 | 2021-2025 | Prolia, Evenity, Otezla |
| Amneal Pharmaceuticals LLC | $40.56 | 2022-2023 | Unithroid |
| Abbott Laboratories | $34.56 | 2021-2023 | Freestyle Libre 3 |
| Optos, INC. | $33.93 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Genentech USA, INC. | $32.82 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $30.54 | 2022-2023 | Quviviq |
| Si-Bone, INC. | $30.17 | 2025 | |
| Sunovion Pharmaceuticals INC. | $29.87 | 2022 | |
| Axsome Therapeutics, INC. | $27.25 | 2025 | Auvelity |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.92 | 2022 | |
| Lilly USA, LLC | $23.39 | 2025 | Kisunla |
| Alexion Pharmaceuticals, INC. | $20.13 | 2021 | |
| Allergan, INC. | $19.85 | 2019 | |
| Sumitomo Pharma America, INC. | $19.00 | 2024 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $17.64 | 2021 | |
| Exact Sciences Corporation | $17.40 | 2023 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $16.80 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.00 | 2023 | Horizant |
| Acella Pharmaceuticals, LLC | $15.72 | 2023 | NP Thyroid 60 |
| Linus Health, INC. | $14.61 | 2023 | |
| Scilex Pharmaceuticals INC. | $13.98 | 2019 | |
| Astellas Pharma US INC | $12.79 | 2023 | Veozah |
| Upsher-Smith Laboratories LLC | $12.64 | 2021 | |
| Eisai INC. | $12.42 | 2021 | |
| Cook Medical LLC | $12.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franklin Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.